FDA Approved: MONJUVI — Original Application (Incyte Corporation)

View source ↗

Summary

FDA approved MONJUVI (tafasitamab-cxix) from Incyte as an original biologics license application for adult patients with relapsed or refractory diffuse large B-…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diffuse Large B-cell Lymphoma

Drugs mentioned

• Monjuvi (tafasitamab)

Snippet

ORIG AP for MONJUVI (TAFASITAMAB-CXIX)